Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Abstract

Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.

T Tomsick, T Brott, W Barsan, J Broderick, E C Haley, J Spilker and J Khoury
American Journal of Neuroradiology January 1996, 17 (1) 79-85;
T Tomsick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Brott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Barsan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Broderick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E C Haley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Spilker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Khoury
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

PURPOSE To determine the relationship between the hyperdense middle cerebral artery sign (HMCAS) and neurologic deficit, as evidenced by the National Institutes of Health (NIH) stroke scale score, and to determine the relationship of the HMCAS and the NIH stroke scale score to arteriographic findings after thrombolytic therapy.

METHODS Fifty-five patients with acute ischemic stroke were rated on the NIH stroke scale, were examined with CT, and were treated with intravenous alteplase within 90 minutes of symptom onset. Presence of the HMCAS was determined on the baseline CT scan by a neuroradiologist blinded to the patient's neurologic deficit. Patients with the HMCAS were compared with those without HMCAS with regard to baseline NIH stroke scale score, 2-hour NIH stroke scale score, findings at posttreatment arteriography, 3-month residual neurologic deficit, and 3-month ischemia volumes as evidenced on CT scans.

RESULTS Eighteen patients (33%) had the HMCAS. These patients had a median baseline NIH stroke scale score of 19.5 compared with a median score of 10 for the patients lacking the HMCAS sign. At 3 months, one (6%) of the HMCAS-positive patients was completely improved neurologically compared with 17 (47%) of the HMCAS-negative patients. Restricting analysis to those patients with a stroke scale score of 10 or greater (n = 37), 18 HMCAS-positive patients showed less early neurologic improvement, were less likely to be completely improved at 3 months, and had larger infarcts compared with the 19 HMCAS-negative patients. Compared with the HMCAS-positive and HMCAS-negative patients with a stroke scale score of 10 or greater, patients with a stroke scale score of less than 10 had fewer occlusive changes of the internal carotid and middle cerebral arteries on posttreatment arteriograms and had a better neurologic recovery at 3 months.

CONCLUSION The presence of the HMCAS on CT scans obtained within 90 minutes of stroke onset is associated with a major neurologic deficit, and in this study it predicted a poor clinical and radiologic outcome after intravenous thrombolytic therapy. However, a major neurologic deficit, defined as a stroke scale score of 10 or more, was better than a positive HMCAS as a predictor of poor neurologic outcome after thrombolytic therapy. Patients with a low stroke scale score (< 10) may benefit from ultraearly intravenous alteplase therapy.

  • Copyright © American Society of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology
Vol. 17, Issue 1
1 Jan 1996
  • Table of Contents
  • Index by author
Advertisement
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
T Tomsick, T Brott, W Barsan, J Broderick, E C Haley, J Spilker, J Khoury
American Journal of Neuroradiology Jan 1996, 17 (1) 79-85;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
T Tomsick, T Brott, W Barsan, J Broderick, E C Haley, J Spilker, J Khoury
American Journal of Neuroradiology Jan 1996, 17 (1) 79-85;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Endovascular treatment for large vessel occlusion stroke in patients with ventricular assist devices
  • Interventionalist Perspective on the New Endovascular Trials
  • Early Reperfusion Rates with IV tPA Are Determined by CTA Clot Characteristics
  • Hounsfield unit value and clot length in the acutely occluded vessel and time required to achieve thrombectomy, complications and outcome
  • Imaging and Treatment of Patients with Acute Stroke: An Evidence-Based Review
  • Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke
  • Clot Burden Score on Admission T2*-MRI Predicts Recanalization in Acute Stroke
  • Multisociety Consensus Quality Improvement Guidelines for Intra-Arterial Catheter-Directed Treatment of Acute Ischemic Stroke: Implications for Neuroradiology and Stroke Centers
  • Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Thin-Slice Reconstructions of Nonenhanced CT Images Allow for Detection of Thrombus in Acute Stroke
  • Response to Letter Regarding Article, "Current Status of Endovascular Stroke Treatment"
  • Quantification of Thrombus Hounsfield Units on Noncontrast CT Predicts Stroke Subtype and Early Recanalization after Intravenous Recombinant Tissue Plasminogen Activator
  • Who should treat stroke?
  • CT and MRI Early Vessel Signs Reflect Clot Composition in Acute Stroke
  • Assessment of Thrombus in Acute Middle Cerebral Artery Occlusion Using Thin-Slice Nonenhanced Computed Tomography Reconstructions
  • Equipoise among recanalization strategies
  • Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial
  • Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
  • Stroke quiz
  • Accuracy of Transcranial Doppler Compared With CT Angiography in Diagnosing Arterial Obstructions in Acute Ischemic Strokes
  • Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance
  • Out-of-hours imaging of acute neurological disease
  • Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force
  • Oxfordshire Community Stroke Project Clinical Stroke Syndrome and Appearances of Tissue and Vascular Lesions on Pretreatment CT in Hyperacute Ischemic Stroke Among the First 510 Patients in the Third International Stroke Trial (IST-3)
  • Hyperdense Internal Carotid Artery Sign: A CT Sign of Acute Ischemia
  • Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign
  • Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
  • The Interventional Management of Stroke (IMS) II Study
  • Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
  • The Hyperdense Posterior Cerebral Artery Sign: A Computed Tomography Marker of Acute Ischemia in the Posterior Cerebral Artery Territory
  • Combined IV and intra-arterial thrombolysis for acute ischemic stroke
  • Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator
  • Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
  • Hyperdense MCA resolved after tPA
  • Intraarterial Thrombolysis: Ready for Prime Time?
  • Tick Tock, Doc: The Rapid Evaluation of Acute Stroke to Direct Therapy and Improve Patient Outcome
  • Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke : Emergency Management of Stroke (EMS) Bridging Trial
  • Hemorrhage Detected Using MR Imaging in the Setting of Acute Stroke: An In Vivo Model
  • Association of Hyperdense Middle Cerebral Artery Sign With Clinical Outcome in Patients Treated With Tissue Plasminogen Activator
  • Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
  • Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
  • Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke
  • Diagnostic Impact and Prognostic Relevance of Early Contrast-Enhanced Transcranial Color-Coded Duplex Sonography in Acute Stroke
  • Prediction of Impending Hemorrhagic Transformation in Ischemic Stroke Using Magnetic Resonance Imaging in Rats Editorial Comment
  • When Is Thrombolysis Justified in Patients With Acute Ischemic Stroke?: A Bioethical Perspective
  • Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire